Retargeted adenoviral cancer gene therapy for tumour cells overexpressing epidermal growth factor receptor or urokinase-type plasminogen activator receptor.

Source:http://linkedlifedata.com/resource/pubmed/id/20410926

Download in:

View as

General Info

PMID
20410926